HEART-FID Trademark

Trademark Overview

On Wednesday, April 5, 2017, a trademark application was filed for HEART-FID with the United States Patent and Trademark Office. The USPTO has given the HEART-FID trademark a serial number of 87399355. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, August 5, 2024. This trademark is owned by Luitpold Pharmaceuticals, Inc.. The HEART-FID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of cardiovascular and hematological disorders; medical and scientific research, namely, conducting clinical trials in the fields of cardiology and hematology
heart-fid

General Information

Serial Number87399355
Word MarkHEART-FID
Filing DateWednesday, April 5, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, August 5, 2024
Registration Number5425012
Registration DateTuesday, March 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements

Goods and ServicesMedical and scientific research in the field of cardiovascular and hematological disorders; medical and scientific research, namely, conducting clinical trials in the fields of cardiology and hematology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 11, 2017
Primary Code042
First Use Anywhere DateThursday, August 31, 2017
First Use In Commerce DateThursday, August 31, 2017

Trademark Owner History

Party NameAMERICAN REGENT, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSHIRLEY, NY 11967
Party NameLuitpold Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressShirley, NY 11967
Party NameLuitpold Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShirley, NY 11967
Party NameLuitpold Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShirley, NY 11967

Trademark Events

Event DateEvent Description
Saturday, April 8, 2017NEW APPLICATION ENTERED
Wednesday, August 16, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 27, 2017ASSIGNED TO EXAMINER
Tuesday, June 27, 2017NON-FINAL ACTION E-MAILED
Tuesday, June 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 27, 2017NON-FINAL ACTION WRITTEN
Wednesday, August 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 11, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2018USE AMENDMENT FILED
Wednesday, January 17, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 13, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 3, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, January 17, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 2, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 3, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 5, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 5, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, July 31, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, January 23, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 14, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 25, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15

Related Keywords

heart medical research scientific trials fields hematology clinical cardiology disorders field